|
|
||||||||
Published online before print January 24, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Internal Medicine I, University of Regensburg, Germany
1Correspondence: Department of Internal Medicine I, University of Regensburg, D-93042 Regensburg, Germany. E-mail: christa.buechler{at}klinik.uni-regensburg.de
Adiponectin (APM) is an adipocyte-derived adipokine with immunosuppressive, antidiabetic, and antiatherosclerotic properties. Low molecular weight (LMW)- and higher molecular weight (HMW)-APM circulate in the serum and activate different signaling pathways. We were interested to see whether LMW-APM exerts different effects on monocytic cells compared with the HMW isoform. Therefore, the effects of recombinant LMW-APM produced in insect cells and the APM from higher eukaryotic cells containing HMW forms on monocytic cells were investigated with respect to apoptosis and inflammation. LMW- and HMW-APM induce apoptosis in nondifferentiated THP-1 cells, reduce macrophage scavenger receptor (MSR) A mRNA expression, and stimulate phosphorylation of adenosine monophosphate-activated protein kinase (AMPK). However, HMW-APM induces the secretion of interleukin (IL)-6 in human monocytes and THP-1 cells but does not suppress lipopolysaccharide (LPS)-induced IL-6 secretion. In contrast, LMW-APM reduces LPS-mediated IL-6 release and furthermore, stimulates IL-10 secretion, most likely by reducing the abundance of inhibitor of nuclear factor (NF)-
B kinase ß, leading to a diminished nuclear translocation of NF-
B p65. Our data indicate that the different APM isoforms do share common effects on monocytic cells but also induce isoform-specific responses. Although apoptosis, the activation of AMPK, and the reduction of MSR are mediated by all APM isoforms, only LMW-APM displays anti-inflammatory properties.
Key Words: endotoxin inflammation adipokine diabetes
This article has been cited by other articles:
![]() |
N. K. Gabler and M. E. Spurlock Integrating the immune system with the regulation of growth and efficiency J Anim Sci, April 1, 2008; 86(14_suppl): E64 - E74. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Haugen and C. A. Drevon Activation of Nuclear Factor-{kappa}B by High Molecular Weight and Globular Adiponectin Endocrinology, November 1, 2007; 148(11): 5478 - 5486. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Neumeier, J. Weigert, R. Buettner, J. Wanninger, A. Schaffler, A. M. Muller, S. Killian, S. Sauerbruch, F. Schlachetzki, A. Steinbrecher, et al. Detection of adiponectin in cerebrospinal fluid in humans Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E965 - E969. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schaffler, U. Muller-Ladner, J. Scholmerich, and C. Buchler Role of Adipose Tissue as an Inflammatory Organ in Human Diseases Endocr. Rev., August 1, 2006; 27(5): 449 - 467. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |